China’s Chesir Eyes Merck KGaA’s €1 Billion Pigments Arm

Chinese Premier Tells German CEOs to Take Lead on ‘De-risking’

Merck Sues US, Calling Move to Cut Drug Prices ‘Extortion’

Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data

Drug Companies Are Minting Billions on Unproven Treatments With FDA Shortcut